Mannosylated fisetin/carveol lipid nanocapsules: brain-targeted dual therapy for modulation of epileptogenesis and cognitive deficits.

Drug Deliv Transl Res · 2026 · PMC13038668 · PMID 40783676

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

quite significantp ≤ 0.05actually significant

Groups receiving FS or CAR showed quite significant prolongation in time to fall compared to the PTZ- group ( p ≤ 0.05) which was further increased by the FS/CAR combination (16.2 ± 2.17, 16 ± 1.41 and 24.75 ± 3.73 s for FS, CAR and FS/CAR, respectively).

also in 5,705 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.